In particular, in view of the variable duration of the production cycle of species, other than salmon, and of the potential occurrence of parasites in the juvenile phase, together with the tendency of operators to postpone as far as possible any courses of treatment due to the frequency limit, in the first year of the life cycle, a high mortality rate of fry and juveniles has been reported. Therefore, for other species than salmon, it is appropriate to align the frequency and maximum number of parasite treatments with the frequency limits set for other chemically synthesised allopathic veterinary medicinal products to permit to intervene when it is really necessary and to avoid high mortality in the first stages of the life cycle.
Recital 6, Regulation (EU) 2021/716
In forcesince 9 Feb 2021